Deal Library / Pharma BD Deal Intelligence
Bayer AG — Pharma Deals
The Pharma Closeout tracks 23 deals, $138.7B in disclosed deal value, 12 with a post-close Outcome Score for Bayer AG.
Median Critic Score: 78 · Median Outcome Score: 52
Best outcome: Bayer AG / Schering AG (79) · Weakest outcome: Bayer AG / Monsanto Company (35)
All 23 deals
- Bayer AG / Schering AG — 2006 · $21.5B · Worked — the deal delivered on its rationale.
- Bayer AG / BlueRock Therapeutics — 2002 · $600M · Worked — the deal delivered on its rationale.
- Bayer AG / Merck Consumer Health — 2014 · $14.2B · Largely worked — most objectives met.
- Bayer AG / Schering AG (residual squeeze-out) — 2007 · $985M · Largely worked — most objectives met.
- Bayer AG / Arvinas, Inc. — 2019 · $1.0B · Mixed — partial payoff, real shortfalls.
- Bayer AG / Merck & Co. Inc. — 2014 · $14.2B · Mixed — partial payoff, real shortfalls.
- Bayer AG / Asklepios BioPharmaceuticals — 2020 · $2.0B · Mixed — partial payoff, real shortfalls.
- Bayer AG / Viralgen — 2020 · Mixed — partial payoff, real shortfalls.
- Bayer AG / Cutter Laboratories — 1974 · Mixed — partial payoff, real shortfalls.
- Bayer AG / Algeta ASA — 2002 · $2.9B · Mixed — partial payoff, real shortfalls.
- Bayer AG / Algeta ASA — 2013 · $2.9B · Underwhelmed — fell short of the thesis.
- Bayer AG / Monsanto Company — 2016 · $63.0B · Underwhelmed — fell short of the thesis.
- Bayer AG / Perfuse Therapeutics, Inc. — 2026 · $2.5B
- Bayer AG / Dewpoint Therapeutics Inc. — 2024 · $424M
- Bayer AG / Mammoth Biosciences Inc. — 2022 · $1.0B
- Bayer AG / Vividion Therapeutics, Inc. — 2021 · $2.0B
- Bayer AG / Asklepios BioPharmaceutical, Inc. (AskBio) — 2020 · $4.0B
- Bayer AG / Recursion Pharmaceuticals, Inc. — 2020 · $1.1B
- Bayer AG / KaNDy Therapeutics Ltd. — 2019 · $875M
- Bayer AG / BlueRock Therapeutics LP — 2019 · $600M
- Bayer AG / Loxo Oncology, Inc. — 2017 · $1.6B
- Bayer AG / Schiff Nutrition International, Inc. — 2012 · $1.2B
- Bayer AG / Onyx Pharmaceuticals, Inc. — 2011 · $160M
← Deal Library ·
Interactive search ·
How we score deals